Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy

Quirino Ciampi1, Sandro Betocchi, Maria Angela Losi

  • 1Department of Clinical Medicine, Cardiovascular & Immunological Sciences, "Federico II" University School of Medicine, Naples - Italy.

Heart International
|October 7, 2011
PubMed

Insights

Wigle's score effectively identifies severe left ventricular hypertrophy (LVH) in hypertrophic cardiomyopathy (HCM) patients, correlating with impaired diastolic function. Other LVH measures did not show this relationship.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is defined by asymmetric left ventricular hypertrophy (LVH) and diastolic dysfunction.
  • The relationship between various LVH assessments and invasive diastolic function indices in HCM requires clarification.

Purpose of the Study:

  • To investigate the correlation between different measures of LVH and invasive hemodynamic parameters of diastolic function in HCM patients.

Main Methods:

  • Twenty-one HCM patients underwent cardiac catheterization to measure pulmonary capillary wedge pressure, left ventricular end-diastolic pressure, and left ventricular volumes.
  • Calculated the time constant of isovolumetric relaxation (τ) and the constant of chamber stiffness (k).
  • Assessed LVH using maximal wall thickness, number of hypertrophied segments, LVH index, and Wigle's score.

Main Results:

  • Wigle's score demonstrated a significant direct correlation with pulmonary capillary wedge pressure, LV end-diastolic pressure, and chamber stiffness (k).
  • Patients with severe LVH (Wigle's score ≥ 8) exhibited significantly higher pulmonary capillary wedge pressure, LV end-diastolic pressure, k, and LV outflow tract gradient compared to those with mild/moderate LVH.
  • No significant differences in the time constant of isovolumetric relaxation (τ) were observed between groups. Other LVH indices did not correlate with diastolic function parameters.

Conclusions:

  • Wigle's score is the sole index of LVH that significantly correlates with invasive measures of diastolic function in HCM.
  • This finding highlights the clinical utility of Wigle's score in assessing diastolic impairment severity in HCM.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...